PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial

Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.

Renowned leaders in neurology, movement disorders, and commercialization join to shape Celeste® market strategy

Funding supports key milestones as the Pivotal, Phase 3 trial surpasses 200 enrolled participants.

PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.

Pivotal Trial for Improving Overall Function and Quality of Life

PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization